GRANULES vs IPCALAB: Stock Comparison
IPCA LABORATORIES is the larger company by market capitalisation. GRANULES INDIA shows a lower P/E and faster revenue growth, while IPCA LABORATORIES shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
GRANULES leads 3; IPCALAB leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | GRANULES | IPCALAB |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | GRANULES | IPCALAB |
|---|---|---|
| Live Price | ₹847.9 | ₹1,937 |
| Day Change | 1.26% | 0.56% |
| Volume | 2.71 L | 31,258 |
| 52-Week High | ₹923.65 | ₹2,038 |
| 52-Week Low | ₹529.85 | ₹1,268 |
| Distance from 52W High | -8.2% | -4.96% |
Valuation
| Metric | GRANULES | IPCALAB |
|---|---|---|
| Market Cap | ₹23,331 Cr | ₹49,328 Cr |
| P/E Ratio | 31.22x | 37.34x |
| P/B Ratio | 4.1x | 6.07x |
| EPS | ₹26.92 | ₹51.63 |
| Book Value | ₹205.21 | ₹317.84 |
| Dividend Yield | 0.21% | 0.31% |
Growth
| Metric | GRANULES | IPCALAB |
|---|---|---|
| Revenue Growth (TTM YoY) | 22.8% | 6.2% |
| EPS Growth (TTM YoY) | 31.3% | 341.6% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | GRANULES | IPCALAB |
|---|---|---|
| ROE | 9.11% | 14.19% |
| ROCE | 9.07% | 14.74% |
| Net Margin | 11.15% | 11.83% |
| Operating Margin | 17.19% | 21.48% |
| Debt to Equity | 0.17x | 0.03x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | GRANULES | IPCALAB |
|---|---|---|
| Promoter Holding | 37.08%▼ 0.59 pp | 44.72% |
| FII Holding | 20.25%▲ 2.75 pp | 11.53%▲ 0.8 pp |
| DII Holding | 15.33%▼ 0.78 pp | 36.59%▼ 0.78 pp |
| Public Holding | 27.04%▼ 1.34 pp | 7.15%▼ 0.03 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and IPCA LABORATORIES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.